South Africa’s health minister hails new HIV prevention jab but warns of limited supply
South Africa aims to prevent new HIV infections with lenacapavir, targeting 456,000 people in two years, funded by a $29.2 million Global Fund grant.
- South Africa's Health Minister, Aaron Motsoaledi, called lenacapavir a groundbreaking method for HIV prevention, despite the limited initial supply of nearly half a million doses for the country with the highest HIV prevalence rate.
- The jab is set to launch in April 2026 and will be funded by a $29.2 million Global Fund grant and $5 million from the Networking HIV and AIDS Community of Southern Africa.
- Motsoaledi cautioned against complacency due to recent funding cuts from USAID affecting HIV/AIDS treatment programs in South Africa.
- UNAIDS South Africa's country director, Eva Kiwango, stated that the jab could be a game changer if it becomes widely accessible, potentially helping to end AIDS as a public health threat in the country.
13 Articles
13 Articles

South Africa's health minister hails new HIV prevention jab but warns of limited supply
South Africa's health minister has called lenacapavir, the first twice-yearly HIV prevention jab, a "groundbreaking" tool against the disease.
The six-monthly anti-HIV jab is coming. But can SA keep track of millions of users? – The Mail & Guardian
In April next year, South Africa plans to start rolling out an anti-HIV jab, taken only twice a year, that could end Aids in the country within 14 to 18 years — if enough people take it. The once-every-six-months shot, called lenacapavir (LEN), works 100% of the time to stop young women from getting HIV through sex. Of the about 400 people in South Africa who still get infected with HIV each day — 122 of them are teen girls and young women. T…
Coverage Details
Bias Distribution
- 77% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium